⌘K

Login Start Free

Home/Filings/4/0001437749-25-006724

4//SEC Filing

Talukdar Lavina 4

Accession 0001437749-25-006724

CIK 0001645469other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 7:51 PM ET

Size

8.7 KB

Accession

0001437749-25-006724

Insider Transaction Report

Form 4

Period: 2025-03-04

Monopar TherapeuticsMNPR

Talukdar Lavina

Director

Transactions

Award
Stock Options
2025-03-04+5,683→ 5,683 total
Exercise: $31.70Exp: 2035-03-04→ Common Stock (5,683 underlying)

Footnotes (1)

[F1]Options vest 25% quarterly on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025

Documents

2 files

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1

filerCIK 0002059193

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 7:51 PM ET
Size: 8.7 KB

View on SEC.gov